Ung Yee Tze, Ong Chin Eng, Pan Yan
Department of Biomedical Science, the University of Nottingham Malaysia Campus, Jalan Broga, Semenyih 43500, Selangor, Malaysia.
School of Pharmacy, International Medical University, Bukit Jalil 57000, Wilayah Persekutuan Kuala Lumpur, Malaysia.
High Throughput. 2018 Sep 29;7(4):29. doi: 10.3390/ht7040029.
Cytochrome P450 (CYP) is a critical drug-metabolizing enzyme superfamily. Modulation of CYP enzyme activities has the potential to cause drug⁻drug/herb interactions. Drug⁻drug/herb interactions can lead to serious adverse drug reactions (ADRs) or drug failures. Therefore, there is a need to examine the modulatory effects of new drug entities or herbal preparations on a wide range of CYP isoforms. The classic method of quantifying CYP enzyme activities is based on high-performance liquid chromatography (HPLC), which is time- and reagent-consuming. In the past two decades, high-throughput screening methods including fluorescence-based, luminescence-based, and mass-spectrometry-based assays have been developed and widely applied to estimate CYP enzyme activities. In general, these methods are faster and use lower volume of reagents than HPLC. However, each high-throughput method has its own limitations. Investigators may make a selection of these methods based on the available equipment in the laboratory, budget, and enzyme sources supplied. Furthermore, the current high-throughput systems should look into developing a reliable automation mechanism to accomplish ultra-high-throughput screening in the near future.
细胞色素P450(CYP)是一种关键的药物代谢酶超家族。CYP酶活性的调节有可能导致药物-药物/草药相互作用。药物-药物/草药相互作用可导致严重的药物不良反应(ADR)或药物治疗失败。因此,有必要研究新的药物实体或草药制剂对多种CYP同工型的调节作用。定量CYP酶活性的经典方法基于高效液相色谱(HPLC),该方法耗时且耗费试剂。在过去二十年中,已开发出包括基于荧光、基于发光和基于质谱的检测方法在内的高通量筛选方法,并广泛应用于评估CYP酶活性。一般来说,这些方法比HPLC更快,且试剂用量更少。然而,每种高通量方法都有其自身的局限性。研究人员可根据实验室现有的设备、预算和提供的酶源来选择这些方法。此外,当前的高通量系统应考虑在不久的将来开发一种可靠的自动化机制,以实现超高通量筛选。